East West Pharma’s Participation in ERO-OGCON 2025

As part of a broader strategy to engage actively at district-level conferences to better align with specific needs, East West Pharma participated in the district-level Gynaecology conference organized by the Erode Obstetric and Gynaecological Society (ERO-OGCON) on February 15th and 16th, 2025. This was the second annual meet of ERO-OGCON, held under the theme “Unlock the Conundrum of Day-to-Day Gynaecology Practice and Whiten Out the Grey Zone.”, and witnessed the convergence of around 250 delegates

The theme of the conference resonated well with our mission to address complex challenges in Gynaecology practice through high-quality pharmaceutical solutions. The conference provided an excellent platform for East West Pharma to engage with prominent Gynaecologists, exchange insights, and showcase our innovative product portfolio tailored to meet the evolving needs of gynaecological practice.
During the event, our display hub attracted significant attention from delegates, where we highlighted our key products, including ENDOBLIS and DYDROTREAT, which have been well received since their launch. The stall had a footfall of more than 100 delegates and our team actively interacted with the attendees, discussing clinical challenges and exploring how our solutions can enhance patient care in gynaecology.

By being present at these focused events, East West Pharma aims to strengthen its relationship with key opinion leaders, gain valuable feedback, and stay attuned to the evolving demands of gynaecological practice.